NCT05547412 (VOICE) is a clinical trial of NovaGuide 2 Intelligent Ultrasound System in Stroke, sponsored by NovaSignal Corp..

Who is sponsoring NCT05547412?

NCT05547412 is sponsored by NovaSignal Corp..

What drugs are being tested in NCT05547412?

Interventions in NCT05547412: NovaGuide 2 Intelligent Ultrasound System.

What condition does NCT05547412 study?

NCT05547412 studies Stroke, Acute Ischemic Stroke.

Is NCT05547412 still recruiting?

NCT05547412 is currently terminated. Last updated 9 April 2024.

Are results published for NCT05547412?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-04-09 · How we verify

NCT05547412: VOICE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke

Terminated Results posted Last updated 9 April 2024

What this trial tests

trial testing NovaGuide 2 Intelligent Ultrasound System in Stroke in 27 participants. Terminated before completion.

Timeline

21 September 2022

Primary endpoint
16 January 2023

31 January 2023

Quick facts

Lead sponsor	NovaSignal Corp.
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	27
Start date	21 September 2022
Primary completion	16 January 2023
Estimated completion	31 January 2023
Sites	1 location across United States

Drugs / interventions tested

NovaGuide 2 Intelligent Ultrasound System

Conditions studied

Stroke — all drugs for Stroke →
Acute Ischemic Stroke — all drugs for Acute Ischemic Stroke →

Sponsor

NovaSignal Corp.

Who can join

18 and older, any sex, with Stroke or Acute Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a multi-center, multi-phase, multi-cohort, prospective, randomized, open, blinded endpoint (PROBE), non-significant risk (NSR) device study including up to 420 evaluable subjects measured with the study device(s) and up to 40 non-evaluable subjects for the training phase.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other NovaSignal Corp. trials

Trials by the same sponsor.

NCT04604015 — RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05547412 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NovaSignal Corp.
Last refreshed: 9 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05547412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing